T-VEC Immunotherapy Now Injected Into Liver Metastases T-VEC Immunotherapy Now Injected Into Liver Metastases

This oncologic immunotherapy, already approved for melanoma in the United States, is being explored for use in advanced liver metastases, with encouraging early safety results.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news